RICHMOND, Va., July 25, 2019 /PRNewswire/ -- On July 19, 2019, Five Arrows Capital Partners (FACP) completed an equity recapitalization of Averhealth, a leading provider of substance use disorder (SUD) treatment monitoring, care management and related support services. The company predominantly assists individuals on behalf of criminal justi

BRIDGEWATER, N.J., July 25, 2019 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will release its second quarter 2019 financial results on Thursday, August 1, 2019.Insmed management will ho

HILLSBORO, Ore., July 25, 2019 /PRNewswire/ -- Thermo Fisher Scientific unveiled its most advanced focused ion beam scanning electron microscope (FIB-SEM) for materials science researchers and engineers, the Thermo Scientific Helios 5 DualBeam microscope. The microscope allows users of all experience levels to generate higher-quality results than previous generation

CAMBRIDGE, Mass., July 25, 2019 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Thursday, August 1, 2019 to report its second

Dominating Canada's digital healthcare management through turnkey Access-to-Care and Patient Engagement products, Chronometriq is accelerating its U.S. operations through a partnership with ELLKAY, the leading U.S. Healthcare Connectivity Firm. MONTREAL, July 25, 2019 /PRNewswire/ - 

SAN MATEO, California, July 25, 2019 /PRNewswire/ -- BlueBee is pleased to announce the expansion of its senior management team with the appointment of Pam Cheng, Ph.D., as Vice President of Product Management and Strategy. Pam joins BlueBee with expertise in clinical bioinformatics honed from her years of experience at Illumina, Compl

SALT LAKE CITY, July 25, 2019 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it will report its calendar second quarter 2019 financial results by press release on Thursday, August 8, 2019 at approximately

LEXINGTON, Mass., July 25, 2019 /PRNewswire/ -- TARIS Bio™, a biopharmaceutical company developing transformational therapies to treat people with debilitating urological disorders, announced today that results of the company's Phase 1b study of TAR-302 for the treatment of overactive bladder (OAB) will be presented in a podium se

SAN DIEGO, July 25, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will participate in the 39th Annual Canaccord Genuity Growth Conference in Boston, MA.  Laurie Stelzer, senior vice president and chief financial officer, will provid

SAN CARLOS, Calif. and WASHINGTON, July 25, 2019 /PRNewswire/ -- GO2 Foundation for Lung Cancer (a merger of the Lung Cancer Alliance and the Bonnie J. Addario Lung Cancer Foundation) announced today that it presented Solange Peters, MD, PhD, with the 2019 Bonnie J. Addario Lectureship Award for her emphasis on groundbr